Th e pr ognostic vari ables of 223 consecutively sam pled sponta neous mammar y tum ors from fem ale dogs were studied. Th ese vari abl es included flow cyto metric DNA analysis and cell proliferat ion mea sur ed as cells in S-ph ase rate eva luated fro m D NA histogram s. Th e dogs were surgically treat ed , in mos t cases wit h unilat eral mastectom y (all mam mary glands), and 202 of th e 223 dogs were stud ied tem porally following surgery. Univa riate analysis with correction for age indi cated that the variables of lymph nod e metastasis, elevated S-phas e rat e, presen ce of a sarcoma, DNA aneuploidy, and ulcerati on and infiltrative growth int o und erl ying tissue had a statistically significant negat ive influence on th e sur vival rates of dogs with a d iagnosed malignant tum or. Simi lar results were obtained from tests on all dogs, but tumo r size and its relat ive hazard increase d with increasing size of the tumors, regard less of whet her total or d isease-specific mort alit y was cons ide red. Using mul tiva riate-analysiscon du cted Co x's proportion al hazard s mod el, elevated S-phase rate, increased age, and presence of a sarco ma remained statistically significant risk factor s. The prognostic value of DNA ploid y and lymph node status varied dependi ng on cho ice of end point. T he study of tum or growth patt ern and tum or size pro vided no prognostic in for mati on in the m ulti var iate analysis. Flow eytometrie cell ana lysis, incl ud ing S-phase rate and D NA ploid y, is of va lue in pred icting the prognosis of canine ma m ma ry tum ors and can be used as a new pro gnostic tool to improve the preoperative dia gnostics o f can ine mamm ary tumors.
Canine mammary tumors with apparent signs ofmalignancy, such as pronounced infiltr ative growth involving several mammary gland s, ede ma, ulcerated skin, and lymph node metastases, do not present an y diagno stic problems for experienced clinicians. However, becaus e man y canine mammar y tumors are not at an ad vanced stage of development when first detected by owners or clini cian s, th e current or pot ent ial biologic beha vior (hyperpl asia, benign proliferation , malignant tr ansformation) of these tumors is difficult to predict clinically. Becau se sma ll tumor s ha ve clinical characteristics th at are difficult to int erpret, bett er diagnostic tools are needed. A preoperat ive diagnosis th at includes tumor type and/o r prognostic information on th e tumor increases the possibility of adequate treatment. Cytologic diagnostics have been used for th at purpose. ' Progn ostic factors of canine mammary tum or s used in univariate anal yses include th e tumor type, th e growth/ stage, and th e size.4.5.8.,o.I,.2°The prognostic va lue of lymph node status, as determined by hist opathologic exa mination, is equivo cal.v-! '-" Th e valu e of additional information abo ut cell morphology ob- 20 tain ed using flow cytom etr ic DNA analysis of fineneedle aspirates from different types of fresh canine mammary tumors has been show n." Flow cytometri c DNA analysis of canine mammary tumors has shown that an euploidy can also occur in histopathologically benign lesions . 15 .22Canine mammary carcinomas were DNA hypodiploid or hyperd iplo id at a lower ploid y level '5.22than were th e com mo n triploid region s in human breast carcinomas . ' Th e aim of thi s study was to investigate whether determ inat ion of DNA ploid y had any pro gnostic va lue in canine mammary tu m ors. However, th e pro gnostic va lue of other variables was also of interest. T here fore, a multivariate analysis includi ng variables of know n prognostic value was perform ed on cons ecuti vely sampled canine mammary tum ors.
Materials and Methods

Animals
Two hun d red twenty-th ree bit ches with ma mmary tu mors were surgically treated at the Department of Surgery and Medi cine at the Swedish U niversi ty of Agricultura l Sciences. Vet Pathol 30: I. 1993 Prognostic Factors in Canine Mammary T umors 2 1 T he tum or s were consec utively sampled from all dogs treat ed for mammary tum ors from March 1983 unt il April 1987. Th e first app roxima tely 100 dogs in thi s follow-up study were includ ed in a previously described study of the histopathologic findings and the DNA ploid y of the tumors." Further, 84 of the dogs in this second study (dog Nos . 64-166) were includ ed in an other previ ou sly described study of th e cytology in relati on to the DNA ploid y.J4 Most dogs were treat ed by unilateral ma stectom y, but six bit ches were treated with parti al mastectom y. Three d ogs were excluded from th e study because of lack of material for DNA analysis, and two dogs were excluded because th ey had mastiti s.
Clinical variables
Th e tumors were clinic ally staged, mainl y accordi ng to th e TNM syste m (T = the extent of the primary tumor, N = the condition of the regiona l lymph node s, and M = th e absence/ presence of dist ant metasta ses)." Tum or size was measured in em at th e largest diam eter. Tumor growth pattern was di vided int o four groups: I) not fixed to adja cent tissues, 2) fixed to th e overlying skin, 3) fixed to th e und erlying tissues, and 4) any tum or with ulcerated overlying skin. Tumor locatio n was d ivided into fou r group s: left versus right and anterior three vers us posterior two. All dogs that und erwent surgery were clinically and radi ologically free from distant metastases. Th e age of th e dogs at the time of surgery was recorded (mean age = 9.33 years, SD = 2. 1, range = 3-15 year s). Breeds were grouped into nine catego ries according to the Swedi sh Kenn el Club: I) spit z breeds, 2) working breeds, 3) gundogs, 4) scent hounds, 5) terriers, 6) sight hounds, 7) compan ion breed s, 8) toy breeds, and 9) mixed breeds. Som e ana mnestic data were collected; information on a) additional mammary tum ors, i.e., tumor s furth er on in the other mammar y chain, b) multiple tum or s in the surgically treated mammary chain at th e tim e of surgery, c) whether th e dog had been spayed , d) whelpin g status, e) presence of pseud op regnan cy, and f) whether progesterone treatment had been given.
Tissue sampling and histopathologic evaluation
Fresh mammary tumor s were immediat ely placed on ice during the surgical operation. Tum ors were cut int o pieces fro m which adja cent part s were tak en for histopathologic exa mi natio n and DNA measurem ent s. Samples for histopath ologic exa m ination were fixed in 10% neutral buffered form alin. Tumors larger than I ern were divid ed into seve ral defined sam ples. The slides were stain ed with hematoxylin and eosin .
Post-operative diagno sis included histopathologic classification of th e tumors and superior inguinal lymph nod es. Th e lymph nod es were registered as region al when th e tumors were locat ed in one of th e posterior two mammary glands. Tum or classificati on has been previou sly descri bed.JS Benign tumors were classified as adeno ma, papill om a, ben ign mixed tumor, or benign mesenchymal tumor. Th e carci no mas were described as du ctular and lobul ar and th en subclassi fied as non infiltrat ing (in situ carci no ma) or infiltrat ing. Th e du etular carcino mas were subgrouped into solid, papillary, scirrhou s, tubular, complex, or comedo types, depending on th eir growth patt ern . Com plex carci nomas were co mpose d of proliferatin g intralobular du cts and myoepithelium-like cells forming myxoid or chond roid tissue. '? Tumors diagnosed as comedoca rcinoma s had typical int raductal necro ses." Th e lobular carcinomas were treated as on e group becaus e of few tumors (in situ lobular carcinomas, n = 2; infiltrating lobul ar carcinomas , n = 6). Onl y tumors fulfilling malignant criteria in both epithelial and mesenchymal tumor components were classified as malign ant mi xed tumors. Th e sarcomas were classified acco rdi ng to th eir histopath ology as fibrosar com as or osteosa rcoma s. Fou r tumors gro uped as "others" consisted of nonmammary tumors locat ed in th e mammary glands. Five cases of mammary dyspla sias were also included in the study. These other tum ors and dysplasias were includ ed becau se th ey were clinically classified as mammary tum or s.
Flow cytometric cell analysis DNA analysis of canine mammary tumors has been described in detail." Th e tumors were placed on ice, and chose n sam ples were frozen in liquid nitrogen (-196 C) or in a freezer (-70 C). Cell preparati on was perform ed accordi ng to Vinde lov et al. 2S Chicken red blood cells (CRBC) were used as th e internal standa rd. Canine peripheral blood nucleat ed cells (CBC) combined with CRBC were used as th e extern al sta ndard. Th e CBC and CRBC cells were store d as portion s in a frozen pool and handled in the sam e way as th e tumor cells. The tumors were thawed, and fine-n eedle aspiration was performed. The cells were suspended in citrate buffer (triso dium citrate, pH 7.60) and d ispersed by proteolytic enzyme treatment (trypsin , included in solution A). Th e reaction was interrupted by trypsin inh ibitor (included in solution B, which also contained ribonu clease A), and cells were stained with prop idium iod ide (solutio n C). Th e cells were treat ed at room temperature for 10 minutes in solutio n A, and then solution B was added. After ano ther 10 m inut es, solution C was added . Th e cells were then kept on ice for 15 minutes before the flow cytometric analysis. Most often, at least 10,000 cell nucle i were analyzed in each sample, and most of th e specimens were analyzed seve ral times on different occasions. Each analysis, which included about eight samples, was initiated and terminated by anal yzing the extern al sta ndard cells. Th e flow cytometer used was a FACS 3 Cell Sorter (Becto n Dickin son , Sunnyvale, CA). Th e DNA index (DI) was defined as th e ratio of the modal channel number of the tumor cells to th at of the int ern al stand ard cells (CRBC) in relation to th e mean value of th e rati o of th e externa l sta ndard (CBC : CRBC):
CBC CRBC
The DI was calculated for each different peak in th e tumor. Th e ran ge of dipl oid y was set at ± 2 sta nda rd deviations (SD) of th e mean value of th e rati o CBC : CRBe. Tumor s with DNA values of 1.00 ± 0.06 were considered diploid . Hypodiploid tum ors (DI < 0.94) and hyperdiploid tumors (DI > 1.06) were grouped as aneuploid. Mult iploidy was defined as th e presence of more than one aneupl oid peak. All tum ors defined as aneuploid also co nta ined a dipl oid peak . The coefficient of va riation (CV) was calculate d as th e SD di vided by th e m ean of th e distributi on ex presse d as a percentage. The DNA a na lyses wer e only performed wh en the CV valu es of th e sta nda rd cells wer e :::; 4%. DN A ploidy was classified accord ing to four cat egor ies: hypodiploid , dipl oid , hyperdiploid , and multiploid. The fractio n of cells locat ed betw een GOIG I and G2 pha ses was inte rprete d as proliferat ing cells. T he S-phase rate was esti ma ted fro m th e DN A histograms. T he percentage of cells within give n cha nne l numbers was calc ulated, and th e S-phase was designat ed as low « 5%), m ed ium (5-10%), or high ( > 10%). Cell a na lysis was perfor med a t the begi nning o f the stud y before th e o utcome of th e follow -up st udies was known .
Follow-up
Most dogs were clini cally exa mi ned and had a th oracic radiogra ph I year after surgery. Thereaft er, th e dogs were exa mi ned individ ua lly dep ending on clinica l sym ptoms . All ow ners of th e dogs wer e as ked for permi ssion to perform a post m ortem exa mi na tio n whe n th e dogs di ed or were e ut ha na tize d. Sixtee n dogs were lost to addi tional stud ies: nin e becau se o f lack of foll ow-up data a nd seve n becau se of imm edi at e post-op erative death fro m othe r ca uses. Thus, 202 dogs rem ained for a na lysis. Th e mean length of time fo r additional information a nd st udy was 24.7 months (SD = 15.5, rang e 0.5-69 m onths). The follow-up sta tus was div ided into four categories : I) dogs th at were ali ve at th e end of th e study (n = 66 ); 2) dogs th at di ed/w ere eutha natized because of th eir mammary tumo rs, verified by necropsy, andl o r died with X-ra y ve rified lun g metasta ses (this gro up included two dogs with local recu rren ces, where as th e othe rs had distant metastases) (n = 53) ; 3) dogs th at die d from other d iseases verified by postmort em exa mi na tio n (n = 47); and 4) dogs th at died for unknown reason s, i.e., no postmort em exa mi nation (n = 36). In dogs with m ulti ple malignant tum ors, th e tumor wit h th e m ost m alignan t histop athologic find ings was used fo r foll ow-up grouping (n = 10).
S ta tistics
Survival curves were co m puted using th e Kaplan-Meier meth od ," a nd tests for differences in survival between di fferent gro ups were performed using th e log ra nk test ." The un ivariat e ana lysis was perform ed after co rrec tio n for age and is stric tly speaking a multivariat e ana lysis sho wi ng th e effect of each vari able after co rrection for age.
Th e Cox prop ortional haza rd s mod el for m ult ivariate ana l-ysis was used to study th e effects of different variables o n survi va l while taking other variables int o account. 18 The basic m od el as sum es th at th e hazard (" the in stantaneous death rat e") , h(t l x) , can be writt en h(l l x ) = h o (t)exp({3 ,x , + . .. + (3,. x k ) , wh ere ho(t) is a ba selin e hazard functio n for individuals wit h all explana to ry va riables x " ... , x, eq ua l to O.
T he parameter {3; rep resents th e cha nge in th e loga rithm of th e hazard functio n as th e variable X; increases by one un it , give n that th e othe r va ria bles are unch anged . A posit ive value for (3; im plies an increase in th e hazard fun ct ion , i.e., poor er survival prospects. Th e effect on th e hazard associated wit h the va riable X ; is exp({3,). Result s are give n as relative haza rd s, RH = exp({3;). For a categorized variable such as S-phase, RH shows the haza rd ofa category (e.g., " median") compared with th e re ferenc e cat ego ry (in this case " low" ). For a co ntinuo us variable such as t umor size , RH shows th e haza rd ratio of two in dividuals t hat d iffer by one uni t for th e variable in qu estion .
Va ria bles th at were found to be im portant in th e univariate a na lyses o r th at were of grea t interest a priori were incl ude d in th e multivari at e ana lyses. In so me cases , inclu sion of a variab le red uced th e number of available o bse rv at io ns co nsiderably becau se of m issing dat a . In such cases (e.g., lymph nod e sta tus), m od els with out th is va riable were also estimat ed .
Different end po ints were co nsi de red . Alt ernative stra tegies were also co ns ide red to shed light on th e effects ofm issin g informa tio n abo ut ca uses of death .
Results
Th e mean age of the dogs at the tim e of surgery was 9.33 years (SD = 2. I, range 3-15 years). Forty different breeds were group ed into nine categories: I) spitz breeds (n = 10), 2) working breeds (n = 35), 3) gundogs (n = 28), 4) scent hounds (n = 7), 5) terri ers (n = 27), 6) sight hounds (n = 2), 7) companio n breed s (n = 22), 8) toy breeds (n = 8), and 9) mixed breeds (n = 13).
Th e material consisted of 30% benign and 68% malignant tumors (Tabl e I). In addition, about 2% were mammary dysplasias (lobul ar hyperplasia and mammary duct ectas ia). Some results are from groups with few observations and are thu s less reliable th an those obtai ned from groups with more num erous observation s.
A life table analysis of survival by lymph nod e status, by S-phase level, by DNA ploidy, and by histopath- 
Univariate a nalysis, proportional hazards model
The producti on of prognos tic info rmation of hi sto pathol ogic, flow-cyt orn etric, and clinical va ria bles was investigat ed ( Table 2) in dogs with malignant tum or s a nd end -po int death fro m m amm ary tum or or unknown ca uses (follow -up sta tus 2 a nd 4). The followi ng variab les had significantly increased rela tive hazard s of2-3 .5 : advance d tu m o r growth with fixation of tum or to underl ying tissu e o r ulc erati on , presen ce ofa sarcoma, presen ce of lymph nod e me tas tases , and a hypodipl oid or hyp erdiploid DN A pattern. The relative ha zard in creased with th e age of th e d og by 1.29 per year (P < 0.00 I). Med ium and high S-phase entailed significantly h igh er relative haza rd s as we ll, with a very high esti mate of aro und 18.5 for a high S-phase. However , o nly two dogs had high S-phase levels. Cru de surv iva l (foll ow-up sta tus 2, 3, and 4) a nd death fro m m ammary tumor o r unkn own causes (follow-up sta tus 2 and 4) were ana lyze d in a ll d ogs, a nd uni vari at e ana lysis produced res ults sim ilar to th ose in dogs with m al ignant disease. O nce aga in , a hi gh S-phase en ta iled a very hig h hazard rate (R H = 2 1.99 , 95 % confidence interval = 5. 11-94.68). H owever , so me min or exce ption s were found co nce rn ing tumor size , which ind icated an increasing re lative haza rd with increa sin g size. Multiple tum or s produced a signific antly better prognosis th a n di d the reference gro up with one index tumor, and dogs with beni gn tu mors a nd in situ carcinomas had a decreased re lative hazar d of 0.28-0.44 (9 5% co nfidence interval = O. 14-0.80).
M ultivariate ana lysis, proportional hazard model
Vari abl es chose n for multi variate ana lysis in dogs with m al ignant tum o rs and end -po int death fro m tumor o r unknown ca uses (follow -u p status 2 an d 4) incl ude d age, tu m o r size , tumo r growth pa ttern, histop athology, lymph nod e status, S-phase rate, and DNA ploid y (Table 3) . Tumor growth pattern , lymph node Hellrnen et al. status, and DNA ploidy no longer carried any significant prognostic information . However, for age of the dog, the presence of a sarcoma, and the S-phase rate , the multivariate analysis produced estimates similar to those of the univariate analysis ( Table 3 ). The relative hazard of 15.8 for a high S-phase was somewhat lower than the value in the univariate anal ysis but was still the same order of magnitude. Elevated S-phase rates and DNA multiploidy were the most valuable prognostic variables in dogs with known follow-up, malignant tumors, and end-point death from mammary tumors (RH = 3.80). Age was also of significant prognostic importance (P < 0.05). DNA hypoploidy and hyperdiploidy appeared to be related to the prognosis, but statistical significance was not reached. When information on lymph node status was included, this variable and the S-phase rate gave significant prognostic information.
When analyzing crude survival in all dogs, the variables with the strongest negative effect on survival included elevated S-phase rate and increased age, with relative hazards of 17.99 (high S-phase rate), 2.12 (me- di um S-phase rate), and 1.1 9 (increased age), respectively. Sarcomas also had an increased relative hazard of about 2.62 (P < 0 .01). As in th e univariate analysis, benign tu m ors and in sit u carci nomas had statistically significantly decreased relative hazards of 0.33-0.53 . Inclusion of information on lym ph node status red uced the num ber of available observations severely; only medi um S-phase rate and increased age had increased relative hazards that were statistically significant (2. 18 an d 1.23 , respectively).
Flow cytometric cell ana lyses and survival tim e in relation to the histopathologic diagno ses
Some of th e diagnosed ben ign tumors were ane uploid and a few tumors also had medium elevated S-p hase levels (Table 4 ). Although subtyping of the carc inomas resulted in few observations for some types, prognostic information, altho ugh not sta tistica lly significant, was availab le for some subtypes. Although onl y two dogs with complex carcinomas (n = 11) died from their mammary tu m ors, survival time was short (mean = 5.3 months, range = 1.5-39). Five ofthe seven dogs with come do carcino mas d ied from their tum ors, an d survival time was rat her short (mea n = 8.4 m onths, range = 0.8-25) ( Table 5 ).
Discussion
This pro specti ve study of consec utively sampled tumors was performed to im prove un derstanding of prognostic factors in canine mammary tumors. The objective was to find out whether improved cell analyzing met hods of DNA ploid y and proli ferating cells were of any additiona l prognostic val ue.
An elevated S-phase rate was a sta tis tica lly significa nt prog nostic factor in all gro ups studied in both univariate and mu ltivariate analyses. This finding is in agree ment wit h those of a study of hum an breast carcino m as." The S-phase rate in the present study was based on th e percentage of cells located bet ween the GO/ G 1 and G2 phase cells. There are difficu lties in interpreting the S-phase concentrations in the aneuploid tumor histograms beca use the cell phases from eac h cell popu lati on interfere with each other. Des pite thes e difficulties, the di fferences in prognosis among gro ups of dogs divide d according to th e interpreted S-p hase concentrations were clearly significa nt , which indicates that future studies of cell division act ivity in canine mam m ary tumors are relevant. These studies should be performed using incorporated bromodeoxyuridine stud ies combined with studies of total DNA content. 6 T he underlying mec ha nisms for increased cell division activity (giving a higher S-p hase rate) are m ultifactorial. There are several hormones, oncogenes , and growth factors that are growth promoting for mamm ary glands and their tum ors." The S-p hase rate probably reflects so me aspects of th eir complex interaction.
Lymph node status was , as expected, of statistically significant prognostic value. When lym ph node status was included in the multivariate analysis it was of greater prognostic va lue than D NA ploidy in dogs wit h known follow-up sta tus. However, it gave no significant information wit h regard to the crude survival of all dogs. On e reason for this might be the fact that sarcomas usually spread hematogenously rather than to the regional lym ph nodes." Dogs with sarcomas had a poor prog nos is in this stu dy, whic h is in acco rda nce with other reports.v"
The age of the dog at the time of surgery was a statistically significant prognostic factor, both in univariate and m ultivariate analyses , for death from the m am m ary tumor. Mammary tum or is a disease of th e m idd le-aged and old bitch , and age was the best prognostic clinical variable.
DNA ploidy was of statistically significant im portance in univariate and multivariate analyses ma in ly in dogs that die d from thei r m ammary tumors. DNA ploidy as a prog nos tic factor in hum an breast carcinoma is equi vocal.tt s-" The differe nt resu lts might depend on whether S-phase analysis , as a probably superior variable," was included in the stu dy or not. DNA ploidy can also vary with in the same tumor in dogs ' S and in hu m an breast carcino mas.' As reflected in canine mammary tumors, hypo diploidy is probably an early event in the tumorogenesis and is follow ed by multiploid y and polyploidy during tumor progression. l s • 22 Thus, ane uploid hu m an breast carcinomas in the common triploid region might represent polyploid tumor cells. As shown in canine mammary tumors, hypodiploid carcinomas, as well as hyper-and multiploid tumors, can cause death of the host. " From this study, however, it seems that multiploid tumors are more aggressive , as shown in dogs that died from their mammary tumors. The prognostic valu e of histopathologic grading ofcanine mammary carcinomas has been described, and this variable probably reflects both cell proliferation and changes (increases) in DNA ploidy.I I Dogs with anaplastic carcinomas, which are the most malignant canine mammary tumors, were not included in our study because these dogs had metastases at the clinical examination and were thus not surgically treated. The anaplastic carcinomas had a specific DNA pattern in the near-diploid region (E. Hellmen and S. Svensson, personal observations). Despite consecutive sampling of mammary tumors, a degree of selection may still have occurred because some dogs were obtained from veterinarians outside the faculty. An overrepresentation oftumors with more clinically malignant behavior can therefore be expected. To generate information relevant to the clinical practice of operating on clinical findings only , all tumor types , i.e., benign and malignant, were included in the study. Their prognoses were analy zed both separately and together.
The choice of end point was based on interest in the effects of different factors on disease-specific mortality. As a starting point, the end point total mortality has been analyzed. This end point can be established without error, whereas data on disease-specific survival ma y not always be available. To sharpen the analysis over the more broad "total mortality" case, the end point "death from mammary tumor or death from unknown causes" has been analyz ed. This is of cours e not the ideal end point because some dogs for which there is no information on the cause of death have been included. The size of the problem can be gauged from the fact that there were 36 of these dogs, which indicates that there were about 18 dogs with other causes of death in this group, as calculated on the basis of the death distribution among the dogs whose cause ofdeath is known. The effect of the inclusion of some dogs with other causes of death in the analysis should be an attenuation of the effects of variables that really influence disease -specific survival, i.e., the effects of such variables were somewhat underestimated. This approach was preferred rather than excluding all dogs with missing information on cause of death or treating them as censored observations, because such restrictions might cause a bias, yielding the sample unrepresentative. The strength in this study is the high percentage of dogs with proper follow-up (including necropsy) that had consecutively sampled tumors.
The explanatory variable that showed the greatest difference when the end point was varied was the DNA ploidy. The importance of DNA ploidy diminishes, however, once S-phase is analyzed. Other variables were surprisingly stable, indicating that the clinical information from these factors is valid for study ofdeaths in dogs with malignant mammary tumors only or study of the outcome for all dogs with mammary tumors. The histopathologic finding of best prognostic value was determination of whether the tumor was a sarcoma or not . Sarcomas (fibro-and osteosarcoma) ha ve specific biological behavior, as evidenced by short survival time and hematogenous spreading of metastases.
T he gro wth pattern of the carcino m as (in situ) and the lym ph no de sta tus were also info rmative . T he prognostic va lue of subtyping th e ductular carci nomas was not significant, but th ere seeme d to be some progno stic informat ion , e.g., in complex and come do subtyping.
Th is study, wh ich is th e first multi vari at e study in ca nine mammary tum ors, indicates th at it is a ppropri at e to per form cell an alysis, includ ing S-phase ra te and, as an alterna tive, DNA ploid y measurem ents. These analyses can provide useful preoperati ve progno sti c informa tion on canine mammary tum or s.
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